Michael RobertsChief Technology Officer (Europe) at Asklepios BioPharmaceutical, Inc.
Michael Roberts is the Chief Technology Officer of AskBio Europe.
Dr Roberts took a first-class honors degree in Biochemistry at the University of Glasgow and subsequently completed his PhD at the University of Cambridge, where he employed viral vectors to study plasticity in the peripheral nervous system. He then proceeded to a post-doctoral position at Royal Holloway, University of London, where he worked on developing novel gene therapies for Duchenne’s Muscular Dystrophy. In 2002 he moved to Greece on a Marie Curie fellowship to set up a functional genomics facility at the National Hellenic Research Foundation.
In 2004 he moved into the Biotech sector, spending five years running Gene Therapy R&D activities for Regulon Inc, joining the board in 2006. In 2010 he moved back to the UK to establish Synpromics and was the founder and chief scientific officer until it was acquired by Asklepios Biopharmaceuticals Inc in 2019.
He is also a member of the Board of Trustees at Medical Research Scotland and a Fellow of the Royal Society of Biology.